Neurogesx, Inc.
Records under this name other than patents Neurogesx, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,943,166 | Methods and Compositions for Administration of TRPV1 Agonists now held by GRT US Holding, Inc. In force · High confidence | In force | High confidence | |
| US 9,951,001 | Hepatoprotectant Acetaminophen Mutual Prodrugs conveyed to Acorda Therapeutics, Inc. Lapsed on the fee record Ended Apr 24, 2026 · High confidence | Lapsed on the fee record | Ended Apr 24, 2026 | High confidence |
| US 11,136,342 | Carbonate Prodrugs and Methods of Using the Same conveyed to Acorda Therapeutics, Inc. Lapsed on the fee record Ended Oct 5, 2025 · High confidence | Lapsed on the fee record | Ended Oct 5, 2025 | High confidence |
| US 9,683,000 | Carbonate Prodrugs and Methods of Using the Same conveyed to Acorda Therapeutics, Inc. Lapsed on the fee record Ended Jun 20, 2025 · High confidence | Lapsed on the fee record | Ended Jun 20, 2025 | High confidence |
| US 11,021,498 | Water-Soluble Acetaminophen Analogs conveyed to Acorda Therapeutics, Inc. Lapsed on the fee record Ended Jun 1, 2025 · High confidence | Lapsed on the fee record | Ended Jun 1, 2025 | High confidence |
| US 8,263,093 | Methods and Compositions for Administration of TRPV1 Agonists now held by GRT US Holding, Inc. Term ended Term ended Apr 12, 2024 · High confidence | Term ended | Term ended Apr 12, 2024 | High confidence |
| US 8,273,390 | Methods and Compositions for Administration of TRPV1 Agonists now held by GRT US Holding, Inc. Term ended Term ended Apr 12, 2024 · High confidence | Term ended | Term ended Apr 12, 2024 | High confidence |
| US 8,734,770 | Methods and Compositions for Administration of TRPV1 Agonists now held by GRT US Holding, Inc. Term ended Term ended Apr 12, 2024 · High confidence | Term ended | Term ended Apr 12, 2024 | High confidence |
| US 9,750,707 | Methods and Compositions for Administration of TRPV1 Agonists conveyed to Acorda Therapeutics Inc. - now held by GRT US Holding, Inc. Term ended Term ended Apr 12, 2024 · High confidence | Term ended | Term ended Apr 12, 2024 | High confidence |
| US 10,653,647 | Methods and Compositions for Administration of TRPV1 Agonists conveyed to Acorda Therapeutics Inc. - now held by GRT US Holding, Inc. Term ended Term ended Apr 12, 2024 · High confidence | Term ended | Term ended Apr 12, 2024 | High confidence |